These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1957904)

  • 1. Ultrasonic tissue characterization of uveal melanoma and prediction of patient survival after enucleation and brachytherapy.
    Coleman DJ; Silverman RH; Rondeau MJ; Coleman JA; Rosberger D; Ellsworth RM; Lizzi FL
    Am J Ophthalmol; 1991 Dec; 112(6):682-8. PubMed ID: 1957904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic Ultrasonography for Surveillance in Patients With Uveal Melanoma.
    Choudhary MM; Gupta A; Bena J; Emch T; Singh AD
    JAMA Ophthalmol; 2016 Feb; 134(2):174-80. PubMed ID: 26633182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
    Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
    Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasonically induced hyperthermia for adjunctive treatment of intraocular malignant melanoma.
    Coleman DJ; Silverman RH; Ursea R; Rondeau MJ; Lizzi FL
    Retina; 1997; 17(2):109-17. PubMed ID: 9143038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survival in choroidal and ciliary body melanoma after enucleation versus plaque radiation therapy.
    Augsburger JJ; Corrêa ZM; Freire J; Brady LW
    Ophthalmology; 1998 Sep; 105(9):1670-8. PubMed ID: 9754176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations of acoustic tissue typing of malignant melanoma and histopathologic features as a predictor of death.
    Coleman DJ; Silverman RH; Rondeau MJ; Lizzi FL; McLean IW; Jakobiec FA
    Am J Ophthalmol; 1990 Oct; 110(4):380-8. PubMed ID: 2220972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ruthenium-106 eye plaque brachytherapy in the conservative treatment of uveal melanoma: a mono-institutional experience.
    Perri P; Fiorica F; D'Angelo S; Lamberti G; Parmeggiani F; Martini A; Carpenteri F; Colosimo C; Micucci M; Perazzini L; De Gugliemo E; Berretta M; Sebastiani A; Cartei F
    Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1919-24. PubMed ID: 23242717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pattern of Local Recurrence After I-125 Episcleral Brachytherapy for Uveal Melanoma in a Spanish Referral Ocular Oncology Unit.
    Sánchez-Tabernero S; García-Alvarez C; Muñoz-Moreno MF; Diezhandino P; Alonso-Martínez P; de Frutos-Baraja JM; López-Lara F; Saornil MA
    Am J Ophthalmol; 2017 Aug; 180():39-45. PubMed ID: 28572063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival after primary enucleation of largest uveal melanomas.
    Gambrelle J; Kodjikian L; Grange JD
    Acta Ophthalmol Scand; 2005 Jun; 83(3):398; 398-9. PubMed ID: 15948802
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ocular retention in patients with uveal melanoma managed by a multimodality approach].
    García-Alvarez C; Muiños Y; Saornil MA; Almaraz A; López-Lara F; Frutos JM; Muñoz MF
    Arch Soc Esp Oftalmol; 2009 Mar; 84(3):145-9. PubMed ID: 19340720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoresection with adjuvant ruthenium brachytherapy for selected uveal melanoma patients - the Tuebingen experience.
    Süsskind D; Dürr C; Paulsen F; Kaulich T; Bartz-Schmidt KU
    Acta Ophthalmol; 2017 Dec; 95(8):e727-e733. PubMed ID: 27914117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uveal melanoma in teenagers and children. A report of 40 cases.
    Shields CL; Shields JA; Milite J; De Potter P; Sabbagh R; Menduke H
    Ophthalmology; 1991 Nov; 98(11):1662-6. PubMed ID: 1800926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cobalt plaque radiotherapy versus enucleation for posterior uveal melanoma: comparison of survival by prognostic index groups.
    Augsburger JJ; Gamel JW; Shields JA
    Trans Am Ophthalmol Soc; 1989; 87():348-59; discussion 359-61. PubMed ID: 2562523
    [No Abstract]   [Full Text] [Related]  

  • 14. Cobalt-60 plaque radiotherapy vs enucleation for posterior uveal melanoma.
    Augsburger JJ; Gamel JW; Lauritzen K; Brady LW
    Am J Ophthalmol; 1990 May; 109(5):585-92. PubMed ID: 2333923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.
    Kaiserman N; Kaiserman I; Hendler K; Frenkel S; Pe'er J
    Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complications in patients with uveal melanoma after stereotactic radiosurgery and brachytherapy.
    Furdova A; Strmen P; Sramka M
    Bratisl Lek Listy; 2005; 106(12):401-6. PubMed ID: 16642665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Forty-year prognosis after plaque brachytherapy of uveal melanoma.
    Stålhammar G
    Sci Rep; 2020 Jul; 10(1):11297. PubMed ID: 32647177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous vitiligo following management of uveal melanoma in 6 patients.
    Rishi P; Shields CL; Patrick K; Shields JA
    JAMA Ophthalmol; 2013 Sep; 131(9):1174-8. PubMed ID: 23887251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collaborative ocular melanoma study randomized trial of I-125 brachytherapy.
    Hawkins BS
    Clin Trials; 2011 Oct; 8(5):661-73. PubMed ID: 22013172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravascular presence of tumor cells as prognostic parameter in uveal melanoma: a 35-year survey.
    Ly LV; Odish OF; Wolff-Rouendaal Dd; Missotten GS; Luyten GP; Jager MJ
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):658-65. PubMed ID: 19797220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.